Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Wasp Stings, Stents, Blood Clots and Traps
  • USA - English


News provided by

WaspBane

Sep 09, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Wasps - a hidden risk?
Wasps - a hidden risk?

London, UK (PRWEB UK) 9 September 2013 -- WaspBane, a spin off business from the NHS and inventors of Integrated Wasp Management and the WaspBane high efficiency wasp trap launched an awareness campaign this week through its Facebook page on its website http://www.waspbane.com to alert members of the public that wasp stings increase the risk of blood clots in coronary stents and that people with stents should avoid purchasing or making low efficiency wasp traps to minimise the risk of being stung by wasps.

it’s about raising awareness so that people with stents who might be at risk can take sensible precautions to avoid being stung by wasps and to seek timely medical advice in the event that they are stung by a wasp.

Post this

Emerging medical data is giving rise to concerns that people fitted with coronary stents may be at risk of developing blood clots in response to wasp stings. Kounis III Syndrome is an allergic type reaction that can be brought on where patients are exposed to allergens and where the body responds by forming blood clots that attack and block coronary stents causing a heart attack (myocardial infarction).

Kounis III Syndrome occurs when immune cells in the body called mast cells become unstable and release antibodies ‘in a flood’ into the blood stream which causes the blood to become sticky and clot. The release of these antibodies ‘in a flood’ is called de-granulation. Stents being foreign bodies act as a magnet for these mast cells and furthermore provide a surface onto which the ‘sticky’ blood can stick.

Wasp venom has evolved over millions of years to contain a whole array of poisons some of which work to cause allergic reactions on purpose. One of these poisons is called mast cell de-granulating peptide and it works by tricking mast cells into releasing their antibodies ‘in a flood’, i.e. it de-granulates them. Another of the poisons in wasp venom, called phospholipase A1, is known to make blood ‘sticky’.

Emerging medical data also suggests that Kounis reactions may be delayed and not necessarily linked with other allergic symptoms such as anaphylaxis. Moreover, because Kounis III Syndrome is a recent discovery it is not yet well known in the medical professions and so is not looked for as a cause of heart attacks in patients with stents. So whilst the ‘recorded’ incidence of patients suffering heart attacks through stents blocked by blood clots caused by wasp stings appears to be rare, there is a worry that more patients may be dying ‘silently’ through miss diagnosed wasp sting induced heart attacks.

“The awareness campaign is not about creating panic or scaring people” says Mr Pazik, who is the managing director at WaspBane, “it’s about raising awareness so that people with stents who might be at risk can take sensible precautions to avoid being stung by wasps and to seek timely medical advice in the event that they are stung by a wasp. It’s about being safe rather than sorry!” Mr Pazik who is a pharmacist also goes on to say “it’s also about raising awareness in the medical professions because there are potential ramifications in the way in which these patients need to be managed and Kounis is not well known. The suspicion is that an unknown number of wasp sting induced Kounis ‘events’ are probably going undiagnosed each year. The awareness campaign is therefore a two pronged effort aimed at prevention, which is always going to be better than cure, and appropriate action in the event of a sting”.

One of the central planks to the awareness campaign is to alert members of the public to the risk of using low efficiency wasp traps which attract more wasps than they kill and therefore increase the number of wasps in their vicinity. “Wasps are incredibly important insects” says Mr Pazik, “and we need them. They pollinate our plants and protect us from harmful pests. The average wasp nest which is little larger than a football will eradicate between 4 and 5 metric tonnes of insect pests in a year! Without wasps we would be faced with all sorts of other diseases and problems caused by insect pests. Sadly wasps do themselves become a health hazard and so have to be managed and that’s where wasp traps come in!”

Low efficiency wasp traps allow wasps to enter, feed and then escape. However, this is not always easy to spot with a busy trap but is high-lighted in a video clip provided by WaspBane hosted on Youtube at http://youtu.be/M0bt_7Tevtc. The escaping wasps go back to the nest and bring back more of their colleagues so increasing the number of wasps in the vicinity of the traps. The WaspBane awareness campaign is working to alert consumers to be wary of wasp trap suppliers making misleading claims that wasps cannot escape from their traps without providing proof. Mr Pazik finishes by saying “It may sound like a trivial matter, but to those people who may be susceptible to wasp stings, it’s a big deal. As a company we believe that making such claims whether wittingly or otherwise where the opposite is true is a breach of the Trades Descriptions Act.”

Karol Pazik, WaspBane, http://www.waspbane.com, +44 1296394142, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.